During the past decade, Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Hemophilia of Georgia, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania" are "Bleeding Disorder" (1 trials), "Connective Tissue Disorder" (1 trials), "Haemophilia A Without Inhibitor" (1 trials), "Haemophilia B Without Inhibitor" (1 trials) and "Hematologic Disorder" (1 trials). Many other conditions were trialed in "Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania" in a lesser frequency.

The vast majority of trials in "Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".